Advancing microbiome therapeutics: Vedanta Biosciences raises US$45.5m in funding

The company has generated a pipeline of microbial treatment programs for infectious diseases, autoimmune diseases, allergies and cancer

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

14 Jun 2021 --- Prinova will become the exclusive European distributor of seven of US-based Compound Solutions’ main ingredients. They include postbiotic CoreBiome and new... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

14 Jun 2021 --- Dolcas Biotech’s highly concentrated ginger root extract Ginfort has proven effective in reducing a range of functional dyspepsia (FD)-related symptoms in a... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

11 Jun 2021 --- As the US gets the COVID-19 pandemic under control and society starts to go back to “normal,” many consumers are wary of the impacts this shift will... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

02 Jun 2021 --- Kerry will lead the sales, marketing and distribution of Bio-Cat’s proprietary probiotic strain, Opti-Biome MB40. 

FormattedPicture

NUTRITION & HEALTH NEWS

28 May 2021 --- Tomorrow will mark World Digestive Health Day (WDHD), which this year is highlighting the link between gut health and obesity. NutritionInsight takes a closer look... Read More

trans